| Representative Experience |
Represented former CEO of Fortune 500 company in various government investigations and related federal multi-district litigation regarding alleged accounting improprieties
CATEGORIES: Litigation
|
Represented defendant charged with assault and robbery in state criminal proceedings
CATEGORIES: Litigation
|
Represented major pharmaceutical company in federal multi-district litigation regarding product-liability claims
CATEGORIES: Litigation
|
Represented auditor in litigation brought by trustee of bankrupt technology company
CATEGORIES: Litigation
|
Represented investment bank and equity analysts in government investigations regarding alleged conflicts of interest
CATEGORIES: Litigation
|
EnvironmentalRepresented a national environmental remediation firm in an internal investigation into allegations raised in-house suggesting a potential pattern of fraudulent billing in connection with certain government contracts. We guided the client as it took remedial action against certain employees and made a voluntary disclosure to the government that included a rebate of the overcharged funds. The company's response not only preserved its ability to continue to perform its existing government contracts, but also prevented disqualification from future government contract work. |
EnvironmentalRepresented a publicly held environmental remediation firm against federal charges of RCRA and Clean Water Act violations. We convinced federal prosecutors not to pursue criminal charges and negotiated a favorable civil and administrative settlement. |
Health CareDefended major pharmaceutical and other companies and their executives and employees in federal and state investigations regarding potential Medicare or Medicaid fraud, including in multi-district litigation concerning alleged pricing fraud |
Health CareAdvised major pharmaceutical, insurance and other companies and public agencies on the implementation of comprehensive compliance programs |
Health CareRepresented a senior executive of a major national medical products and services company in connection with an extensive federal grand jury and Office of Inspector General investigation. Although our client had specifically been identified as a target of the grand jury investigation, we were able to successfully persuade federal prosecutors not to seek an indictment against him. As a result, our client faced no criminal prosecution and is still employed in the health care industry. |
Health CareDefended senior biomedical engineers and others in connection with a federal fraud investigation regarding medical devices and manufacturing processes, as well as economic espionage |
Health CareDefended companies and individuals in federal investigations concerning clinical trial activities and allegations of fraud in connection with obtaining FDA approvals |
Health CareDefended major pharmaceutical companies and their executives and sales representatives in federal anti-kickback and off-label investigations |
Health CareDefended a major specialty pharmacy in a federal false claims act litigation |
Health CareRepresented a major international pharmaceutical company in connection with an investigation by the Office of the Attorney General of Massachusetts of a number of companies that manufacture blood factor concentrates used in the treatment of individuals with hemophilia. The investigation occurred at a very sensitive time for civil litigation throughout the United States related to the alleging transfer of the HIV virus to hemophiliacs through certain blood products. We were able to negotiate a successful resolution in which the attorney general closed his investigation without jeopardizing the then-pending settlement of the civil litigation. |
Health CareRepresented a physicians' group based in one of the major teaching hospitals in Boston in making New England's first successful voluntary disclosure and repayment to the Medicare, Medicaid and CHAMPUS programs pursuant to the Office of Inspector General's voluntary disclosure program. We negotiated a settlement agreement in which no penalties were imposed on the client, and designed a corporate integrity agreement which we believe was the first such agreement to dispense with a retrospective audit requirement in favor of a purely prospective audit protocol. We also advised the client on implementation of a compliance program approved as part of the settlement. |
High TechDefended the founder and CEO of a high technology firm in a federal investigation and related derivative and class actions involving revenue recognition issues |
High TechRepresented high technology companies and their executives in defending against claims of intellectual property or trade secret theft |
High TechDefended a board member and a CTO of a high technology company in a federal money laundering investigation involving alleged international financial transactions |
High TechRepresented high technology companies in connection with intellectual property and technology matters, including pursuing investigations of alleged theft of trade secrets and attacks on computer networks |